Literature DB >> 1550398

Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis.

C Y Tsai1, T H Wu, K H Sun, W M Lin, C L Yu.   

Abstract

Samples of protein from the urine of 23 patients with lupus nephropathy and 15 patients with proteinuria who did not have systemic lupus erythematosus (SLE) were studied for the presence of cytokines, soluble interleukin 2 receptors (sIL-2R), and free light chain immunoglobulins. The patients with lupus nephropathy were divided into two groups with active (nephritis) and inactive inflammation (nephrosis) based on the results of the analysis of urine samples and renal histology. The crude urine proteins (5 mg/ml) after precipitation by 80% ammonium sulphate from 14 patients with lupus nephritis contained higher concentrations of sIL-2R (4.88 (SEM 1.27 ng/ml) than those from nine patients with nephrosis (1.11 (0.52) ng/ml) or 15 patients without SLE (1.31 (0.87) ng/ml). The concentration of sIL-2R in protein from urine samples was not correlated with the concentration in plasma and was inversely correlated with the excretion of protein in urine over 24 hours in patients with SLE. It is suggested that, in addition to leakage from the circulation, the local production of sIL-2R by inflamed kidneys is possible. The crude proteins in urine were further fractionated by gel filtration on Sephacryl S-200. Arbitrarily, four fractions could be obtained from urine from patients with SLE but only three fractions were found in the urine of patients without SLE. Fraction IV derived from patients with nephritis or nephrosis augmented the pokeweed mitogen induced [3H]thymidine uptake of mononuclear cells. In addition, the positive rates of free kappa (kappa) (35.7%) and lambda (lambda) (42.9%) chains in proteins in urine from nephritic patients were higher than those in the other two groups. These results suggest that the severity of inflammation in the kidneys of patients with lupus can be reflected by the increased excretion of sIL-2R, free light chain immunoglobulins, and cytokine-like molecules in urine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550398      PMCID: PMC1005652          DOI: 10.1136/ard.51.2.168

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.

Authors:  Y Tokano; A Murashima; Y Takasaki; H Hashimoto; K Okumura; S Hirose
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

2.  Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain.

Authors:  J E Hopper; E Papagiannes
Journal:  Cell Immunol       Date:  1986-08       Impact factor: 4.868

3.  Immune-mediated mesangial cell injury--biosynthesis and function of prostanoids.

Authors:  R A Stahl; F Thaiss; S Kahf; W Schoeppe; U M Helmchen
Journal:  Kidney Int       Date:  1990-08       Impact factor: 10.612

4.  A thymocyte-activating factor derived from glomerular mesangial cells.

Authors:  D H Lovett; J L Ryan; R B Sterzel
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

5.  A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.

Authors:  P Seckinger; K Williamson; J F Balavoine; B Mach; G Mazzei; A Shaw; J M Dayer
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

6.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

Authors:  S Okuda; L R Languino; E Ruoslahti; W A Border
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

7.  Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL).

Authors:  L Marcon; M E Fritz; C C Kurman; J C Jensen; D L Nelson
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis.

Authors:  H I Werber; S N Emancipator; M L Tykocinski; J R Sedor
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

9.  Soluble cytokine receptors are present in normal human urine.

Authors:  D Novick; H Engelmann; D Wallach; M Rubinstein
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  A human inhibitor of tumor necrosis factor alpha.

Authors:  P Seckinger; S Isaaz; J M Dayer
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  8 in total

1.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

2.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.

Authors:  M Abe; T Goto; M Kosaka; D Wolfenbarger; D T Weiss; A Solomon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome.

Authors:  G H Bock; J R Ongkingco; L T Patterson; J Ruley; L R Schroepfer; D L Nelson
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

4.  Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.

Authors:  Maria Teresa Rocchetti; Massimo Papale; Anna Maria d'Apollo; Ida Valentina Suriano; Anna Maria Di Palma; Grazia Vocino; Eustacchio Montemurno; Leonarda Varraso; Giuseppe Grandaliano; Salvatore Di Paolo; Loreto Gesualdo
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 8.237

5.  Soluble interleukin-2 receptor in patients with glomerular diseases.

Authors:  H S Chen; M S Wu; T S Yen; W Y Chen
Journal:  Postgrad Med J       Date:  1995-10       Impact factor: 2.401

Review 6.  Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.

Authors:  María Morell; Francisco Pérez-Cózar; Concepción Marañón
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 7.  Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems.

Authors:  Song-Chou Hsieh; Chang-Youh Tsai; Chia-Li Yu
Journal:  Open Access Rheumatol       Date:  2016-09-19

8.  Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.

Authors:  Waleed Hassan; Eman Behiry; Marwa Mahgoub
Journal:  Arch Rheumatol       Date:  2020-06-26       Impact factor: 1.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.